Cynapsus Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 1

Cynapsus General Information

Description

Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson's disease. It also completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine.

Contact Information

Website
www.cynapsus.ca
Formerly Known As
Cannasat Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 828 Richmond Street West
  • Toronto, Ontario M6J 1C9
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Sunovion Pharmaceuticals
Corporate Office
  • 828 Richmond Street West
  • Toronto, Ontario M6J 1C9
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cynapsus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.

Request a free trial

Cynapsus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film
Drug Discovery
Toronto, Canada
30 As of 2016

Lexington, MA
 

Jersey City, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cynapsus Competitors (35)

One of Cynapsus’s 35 competitors is Dicerna Pharmaceuticals, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Scynexis Formerly VC-backed Jersey City, NJ
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Corcept Therapeutics Formerly VC-backed Redwood City, CA
Crinetics Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 35 competitors. Get the full list »

Cynapsus Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • Pending

  • Expiring in next 12 mo

Cynapsus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016172095-A1 Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa Inactive 21-Apr-2015
US-10285953-B2 Sublingual films Active 16-Dec-2010
US-20120195955-A1 Sublingual films Active 16-Dec-2010
US-20130225626-A1 Sublingual films Active 16-Dec-2010
US-20140377329-A1 Sublingual films Active 16-Dec-2010 A61F13/00063
To view Cynapsus’s complete patent history, request access »

Cynapsus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cynapsus Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.

Request a free trial

Cynapsus Acquisitions (1)

Cynapsus’s most recent deal was a Merger/Acquisition with Adagio Pharmaceuticals for . The deal was made on 22-Dec-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Adagio Pharmaceuticals 22-Dec-2011 Merger/Acquisition Pharmaceuticals
To view Cynapsus’s complete acquisitions history, request access »

Cynapsus FAQs

  • When was Cynapsus founded?

    Cynapsus was founded in 2004.

  • Where is Cynapsus headquartered?

    Cynapsus is headquartered in Toronto, Canada.

  • What is the size of Cynapsus?

    Cynapsus has 30 total employees.

  • What industry is Cynapsus in?

    Cynapsus’s primary industry is Drug Discovery.

  • Is Cynapsus a private or public company?

    Cynapsus is a Private company.

  • What is the current valuation of Cynapsus?

    The current valuation of Cynapsus is .

  • What is Cynapsus’s current revenue?

    The current revenue for Cynapsus is .

  • How much funding has Cynapsus raised over time?

    Cynapsus has raised $56.3M.

  • Who are Cynapsus’s investors?

    Adage Capital Management, Aisling Capital, Broadfin Capital, DAFNA Capital Management, and Dexcel Pharma are 5 of 12 investors who have invested in Cynapsus.

  • Who are Cynapsus’s competitors?

    Dicerna Pharmaceuticals, Scynexis, BioMarin Pharmaceutical, Corcept Therapeutics, and Crinetics Pharmaceuticals are some of the 35 competitors of Cynapsus.

  • When was Cynapsus acquired?

    Cynapsus was acquired on 21-Oct-2016.

  • Who acquired Cynapsus?

    Cynapsus was acquired by Sunovion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process